|
RAC March 9, 2004 - Presentation Materials |
|
95th Meeting Day 1 |
Bethesda, Maryland |
|
|
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
|
Diane Wara, M.D., Chair, NIH RAC |
|
|
|
Webcast
|
|
|
|
|
|
Discussion of Human Gene Transfer Protocol # 0401-629: |
|
|
|
A Phase I Dose-Escalation Trial of vvDD-CDSR (Double-Deleted Vaccinia Virus Plus CD/SMR) Administered by Intratumoral Injection in Patients with Superficial Injectable Tumors |
|
|
|
David L. Bartlett, M.D., University of Pittsburgh Medical Center |
|
|
|
Webcast
Slides
|
|
|
|
Review |
|
|
|
Genoveffa Franchini, M.D., National Cancer Institute, NIH |
|
|
|
Webcast
Slides
|
|
|
|
David L. Bartlett, M.D. - Response |
|
|
|
Webcast
|
|
|
|
Outcome of Initial Review by RAC Members |
|
|
|
Webcast
|
|
|
|
RAC Recommendations |
|
|
|
Webcast
|
|
|
|
|
|
Update on Protocol 0104-469: |
|
|
|
Subthalamic GAD Gene Transfer in Parkinson's Disease Patients Who Are Candidates for Deep-Brain Stimulatio |
|
|
|
Michael G. Kaplitt, M.D., Ph.D., Weill Medical College, Cornell University, Ithaca, NY |
|
|
|
Webcast
Slides
|
|
|
|
|
ADJOURN |
|
|
|
Top of Page |
|
|
|
|
|